Articles related to PRODUCT RECALL

The presence of small stones in processed chocolate products highlights vulnerabilities in food manufacturing quality control systems, particularly in handling of natural ingredients like almonds.

Manufacturing deficiencies included inadequate contamination prevention and quality control measures, with historical context of previous recalls from the same facility that were associated with patient adverse events.

Unacceptable levels of N-nitroso atomoxetine, a potential carcinogen, were found in multiple atomoxetine batches, according to the FDA.

The FDA gave the recall a class 2 risk level, meaning that drinking the creamers ‘may cause temporary or medically reversible adverse health consequences,’ or that the possibility of serious health consequences is ‘remote.’

Healthcare providers should be vigilant for patients presenting with neurological symptoms, especially if there’s a history of consuming canned tuna products.

N-nitroso-duloxetine poses increased cancer risk at higher concentrations and extended exposure periods, prompting FDA-mandated strict limits on nitrosamine levels in medications.